Durable response without recurrence to Tolvaptan improves long-term survival

被引：0
|
作者：
Masato Nakai
Goki Suda
Akinori Kubo
Yoshimasa Tokuchi
Takashi Kitagataya
Ren Yamada
Taku Shigesawa
Kazuharu Suzuki
Akihisa Nakamura
Naoki Kawagishi
Masatsugu Ohara
Machiko Umemura
Takuya Sho
Kenichi Morikawa
Koji Ogawa
Naoya Sakamoto
机构：
[1] Hokkaido University Graduate School of Medicine,Department of Gastroenterology and Hepatology
来源：
Journal of Gastroenterology | 2020年 / 55卷
关键词：
Tolvaptan; Recurrence; C-reactive protein; Acute kidney injury; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1150 / 1161
页数：11
相关论文
共 50 条
  • [1] Durable response without recurrence to Tolvaptan improves long-term survival
    Nakai, Masato
    Suda, Goki
    Kubo, Akinori
    Tokuchi, Yoshimasa
    Kitagataya, Takashi
    Yamada, Ren
    Shigesawa, Taku
    Suzuki, Kazuharu
    Nakamura, Akihisa
    Kawagishi, Naoki
    Ohara, Masatsugu
    Umemura, Machiko
    Sho, Takuya
    Morikawa, Kenichi
    Ogawa, Koji
    Sakamoto, Naoya
    JOURNAL OF GASTROENTEROLOGY, 2020, 55 (12) : 1150 - 1161
  • [2] LONG-TERM SURVIVAL WITH RECURRENCE OF HYPERNEPHROMA
    STALNIKOWICZ, R
    TOBY, M
    YAGIL, Y
    MOGLE, P
    EUROPEAN UROLOGY, 1983, 9 (03) : 187 - 188
  • [3] Tamoxifen 'improves long-term survival'
    不详
    EUROPEAN JOURNAL OF CANCER, 2001, 37 (01) : 2 - 2
  • [4] Long-term androgen suppression improves survival
    Hutchinson L.
    Nature Reviews Clinical Oncology, 2009, 6 (8) : 438 - 438
  • [5] Acute Response to Tolvaptan in ADPKD: A Window to Predict Long-term Efficacy?
    Reddy, Bharathi
    Chapman, Arlene B.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2015, 65 (06) : 811 - 813
  • [6] Long-term survival and recurrence patterns in ampullary cancer
    Balachandran, Palat
    Sikora, Sadiq S.
    Kapoor, Shalini
    Krishnani, Narendra
    Kumar, Ashok
    Saxena, Rajan
    Kapoor, Vinay K.
    PANCREAS, 2006, 32 (04) : 390 - 395
  • [7] Renal transplantation improves long-term patient survival
    Woo, YM
    Rodger, RSC
    Briggs, JD
    Jardine, AG
    TRANSPLANTATION, 1999, 67 (07) : S146 - S146
  • [8] Durable benefit and the potential for long-term survival with immunotherapy in advanced melanoma
    McDermott, David
    Lebbe, Celeste
    Hodi, F. Stephen
    Maio, Michele
    Weber, Jeffrey S.
    Wolchok, Jedd D.
    Thompson, John A.
    Balch, Charles M.
    CANCER TREATMENT REVIEWS, 2014, 40 (09) : 1056 - 1064
  • [9] Update of acute and long-term tolvaptan therapy
    Imamura, Teruhiko
    Kinugawa, Koichiro
    JOURNAL OF CARDIOLOGY, 2019, 73 (1-2) : 102 - 107
  • [10] LONG-TERM SURVIVAL (APPROACHING 20 YEARS), COMPLETE RESPONSE AND NORMAL CHILDHOOD DEVELOPMENT IN MEDULLOBLASTOMA (PNET) WITHOUT RECURRENCE: A CASE REPORT
    Janicki, Tomasz
    Burzynski, Stanislaw
    Burzynski, Gregory
    Marszalek, Ania
    NEURO-ONCOLOGY, 2014, 16 : 80 - 81
12345